Jeffrey Alan Hawkins Sells 12,149 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 12,149 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $0.83, for a total transaction of $10,083.67. Following the completion of the sale, the chief executive officer owned 3,859,847 shares in the company, valued at $3,203,673.01. The trade was a 0.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The stock was sold at an average price of $0.85, for a total value of $9,883.80.

Quantum-Si Price Performance

Shares of QSI stock opened at $0.85 on Wednesday. Quantum-Si Incorporated has a 12-month low of $0.79 and a 12-month high of $3.10. The firm has a market capitalization of $184.15 million, a price-to-earnings ratio of -1.64 and a beta of 3.00. The business has a 50 day simple moving average of $1.03 and a 200 day simple moving average of $1.36.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The firm had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.76 million. On average, equities analysts anticipate that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on QSI. Canaccord Genuity Group cut their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $3.25.

Institutional Investors Weigh In On Quantum-Si

Institutional investors have recently added to or reduced their stakes in the company. Invesco Ltd. increased its position in shares of Quantum-Si by 177.7% during the 1st quarter. Invesco Ltd. now owns 103,657 shares of the company’s stock valued at $124,000 after purchasing an additional 66,336 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Quantum-Si by 23.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock valued at $85,000 after buying an additional 13,546 shares during the period. Millennium Management LLC acquired a new stake in shares of Quantum-Si in the first quarter valued at $4,721,000. Geode Capital Management LLC boosted its stake in Quantum-Si by 15.1% during the second quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock valued at $6,759,000 after buying an additional 452,850 shares in the last quarter. Finally, Intech Investment Management LLC boosted its stake in Quantum-Si by 44.2% during the second quarter. Intech Investment Management LLC now owns 88,497 shares of the company’s stock valued at $173,000 after buying an additional 27,132 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.